vimarsana.com
Home
Live Updates
Dr Eskander on Pembrolizumab Plus Paclitaxel and Carboplatin in Endometrial Cancer : vimarsana.com
Dr Eskander on Pembrolizumab Plus Paclitaxel and Carboplatin in Endometrial Cancer : vimarsana.com
Dr Eskander on Pembrolizumab Plus Paclitaxel and Carboplatin in Endometrial Cancer
Ramez N. Eskander, MD, discusses findings from the phase 3 NRG GY018 trial of pembrolizumab plus chemotherapy in patients with endometrial cancer.
Related Keywords
Ramezn Eskander ,
,
Reproductive Services ,
Department Of Obstetrics ,
Division Of Gynecologic Oncology ,
Gynecologic Oncology ,
California San Diego Moores Cancer Center ,
D ,
University Of California San Diego Moores Cancer Center ,
Nrg Gy018 Trial ,
Pembrolizumab Plus Chemotherapy ,
Patients With Endometrial Cancer ,
Nct03914612 ,